Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019)

医学 重症监护室 倾向得分匹配 蛛网膜下腔出血 比例危险模型 内科学 回顾性队列研究 人口 危险系数 混淆 创伤性脑损伤 冲程(发动机) 生存分析 机械工程 环境卫生 精神科 工程类 置信区间
作者
Yongwei Huang,Ye Zhang,Zongping Li,Xiao-Shuang Yin
出处
期刊:Frontiers in Immunology [Frontiers Media SA]
卷期号:14 被引量:5
标识
DOI:10.3389/fimmu.2023.1235266
摘要

Non-traumatic subarachnoid hemorrhage (SAH), primarily due to the rupture of intracranial aneurysms, contributes significantly to the global stroke population. A novel biomarker, pan-immune-inflammation value (PIV) or called the aggregate index of systemic inflammation (AISI), linked to progression-free survival and overall survival in non-small-cell lung cancer and mortality in Coronavirus Disease 2019 (COVID-19) patients, has surfaced recently. Its role in non-traumatic SAH patients, however, remains under-researched. This study aims to determine the relationship between PIV and all-cause mortality in non-traumatic SAH patients.A retrospective analysis was conducted using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database to examine the association between PIV and all-cause mortality in critically ill patients with non-traumatic SAH. PIV measurements were collected at Intensive Care Unit (ICU) admission, and several mortality measures were examined. To control for potential confounding effects, a 1:1 propensity score matching (PSM) method was applied. The optimal PIV cutoff value was identified as 1362.45 using X-tile software that is often used to calculate the optimal cut-off values in survival analysis and continuous data of medical or epidemiological research. The relationship between PIV and short- and long-term all-cause mortality was analyzed using a multivariate Cox proportional hazard regression model and Kaplan-Meier (K-M) survival curve analysis. Interaction and subgroup analyses were also carried out.The study included 774 non-traumatic SAH patients. After PSM, 241 pairs of score-matched patients were generated. The Cox proportional hazard model, adjusted for potential confounders, found a high PIV (≥ 1362.45) independently associated with 90-day all-cause mortality both pre- (hazard ratio [HR]: 1.67; 95% confidence intervals (CI): 1.05-2.65; P = 0.030) and post-PSM (HR: 1.58; 95% CI: 1.14-2.67; P = 0.042). K-M survival curves revealed lower 90-day survival rates in patients with PIV ≥ 1362.45 before (31.1% vs. 16.1%%, P < 0.001) and after PSM (68.9% vs. 80.9%, P < 0.001). Similarly, elevated PIV were associated with increased risk of ICU (pre-PSM: HR: 2.10; 95% CI: 1.12-3.95; P = 0.02; post-PSM: HR: 2.33; 95% CI: 1.11-4.91; P = 0.016), in-hospital (pre-PSM: HR: 1.91; 95% CI: 1.12-3.26; P = 0.018; post-PSM: 2.06; 95% CI: 1.10-3.84; P = 0.034), 30-day (pre-PSM: HR: 1.69; 95% CI: 1.01-2.82; P = 0.045; post-PSM: 1.66; 95% CI: 1.11-2.97; P = 0.047), and 1-year (pre-PSM: HR: 1.58; 95% CI: 1.04-2.40; P = 0.032; post-PSM: 1.56; 95% CI: 1.10-2.53; P = 0.044) all-cause mortality. The K-M survival curves confirmed lower survival rates in patients with higher PIV both pre- and post PSM for ICU (pre-PSM: 18.3% vs. 8.4%, P < 0.001; post-PSM:81.7 vs. 91.3%, P < 0.001), in-hospital (pre-PSM: 25.3% vs. 12.8%, P < 0.001; post-PSM: 75.1 vs. 88.0%, P < 0.001), 30-day (pre-PSM: 24.9% vs. 11.4%, P < 0.001; post-PSM:74.7 vs. 86.3%, P < 0.001), and 1-year (pre-PSM: 36.9% vs. 20.8%, P < 0.001; P = 0.02; post-PSM: 63.1 vs. 75.1%, P < 0.001) all-cause mortality. Stratified analyses indicated that the relationship between PIV and all-cause mortality varied across different subgroups.In critically ill patients suffering from non-traumatic SAH, an elevated PIV upon admission correlated with a rise in all-cause mortality at various stages, including ICU, in-hospital, the 30-day, 90-day, and 1-year mortality, solidifying its position as an independent mortality risk determinant. This study represents an attempt to bridge the current knowledge gap and to provide a more nuanced understanding of the role of inflammation-based biomarkers in non-traumatic SAH. Nevertheless, to endorse the predictive value of PIV for prognosticating outcomes in non-traumatic SAH patients, additional prospective case-control studies are deemed necessary.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
是赤赤呀完成签到,获得积分10
刚刚
阮人雄完成签到,获得积分10
刚刚
王饱饱完成签到 ,获得积分10
刚刚
Mr_Hao完成签到,获得积分10
1秒前
Keira_Chang完成签到,获得积分10
1秒前
起承转合完成签到 ,获得积分10
1秒前
风姿物语完成签到,获得积分10
2秒前
xiaopeng完成签到,获得积分10
2秒前
Jenny应助艺玲采纳,获得10
3秒前
一平发布了新的文献求助80
3秒前
樱桃味的火苗完成签到,获得积分10
3秒前
3秒前
波波完成签到,获得积分10
4秒前
322628完成签到,获得积分10
4秒前
领导范儿应助silong采纳,获得10
4秒前
身为风帆发布了新的文献求助10
4秒前
applepie完成签到,获得积分10
4秒前
顾己完成签到,获得积分10
4秒前
宋嬴一完成签到,获得积分10
4秒前
4秒前
我超爱cs完成签到,获得积分10
5秒前
沉静哲瀚完成签到,获得积分10
5秒前
MADKAI发布了新的文献求助10
6秒前
喝汤一样完成签到,获得积分10
6秒前
6秒前
6秒前
wormzjl发布了新的文献求助10
6秒前
虚拟的眼神完成签到,获得积分10
8秒前
陈_Ccc完成签到 ,获得积分10
8秒前
文静达完成签到,获得积分10
8秒前
rui发布了新的文献求助30
8秒前
CC发布了新的文献求助10
8秒前
8秒前
兴奋的果汁完成签到,获得积分10
9秒前
9秒前
9秒前
浮三白完成签到,获得积分10
9秒前
爆米花应助沉静的夜玉采纳,获得10
10秒前
aodilee完成签到,获得积分10
10秒前
思源应助非常可爱采纳,获得20
10秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527304
求助须知:如何正确求助?哪些是违规求助? 3107454
关于积分的说明 9285518
捐赠科研通 2805269
什么是DOI,文献DOI怎么找? 1539827
邀请新用户注册赠送积分活动 716708
科研通“疑难数据库(出版商)”最低求助积分说明 709672